Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins-Reference-Cited by-同舟云学术

Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins

Published:2018-10-11 Issue:10 Volume:4 Page:e182078
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

,Guida Florence¹,Sun Nan²,Bantis Leonidas E.³,Muller David C.⁴,Li Peng¹⁵,Taguchi Ayumu⁶,Dhillon Dilsher²,Kundnani Deepali L.²,Patel Nikul J.²,Yan Qingxiang³,Byrnes Graham⁷,Moons Karel G. M.⁸,Tjønneland Anne⁹,Panico Salvatore¹⁰,Agnoli Claudia¹¹,Vineis Paolo⁴¹²,Palli Domenico¹³,Bueno-de-Mesquita Bas⁴¹⁴,Peeters Petra H.⁸,Agudo Antonio¹⁵,Huerta Jose M.¹⁶¹⁷,Dorronsoro Miren¹⁸,Barranco Miguel Rodriguez¹⁷¹⁹²⁰,Ardanaz Eva¹⁷²¹²²,Travis Ruth C.²³,Byrne Karl Smith²³,Boeing Heiner²⁴,Steffen Annika²⁴,Kaaks Rudolf²⁵,Hüsing Anika²⁵,Trichopoulou Antonia²⁶²⁷,Lagiou Pagona²⁶²⁷²⁸,La Vecchia Carlo²⁶²⁹,Severi Gianluca¹²³⁰,Boutron-Ruault Marie-Christine³⁰,Sandanger Torkjel M.³¹,Weiderpass Elisabete³¹³²³³³⁴,Nøst Therese H.³¹,Tsilidis Kostas⁴³⁵,Riboli Elio⁴,Grankvist Kjell³⁶,Johansson Mikael³⁷,Goodman Gary E.³⁸,Feng Ziding³,Brennan Paul¹,Johansson Mattias¹,Hanash Samir M.²

Affiliation:

1. Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France

2. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

4. Department of Epidemiology and Biostatistics, Imperial College London School of Public Health, London, United Kingdom

5. Laboratory of Population Health, Max Planck Institute for Demographic Research, Rostock, Germany

6. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston

7. Environment and Radiation Section, International Agency for Research on Cancer, Lyon, France

8. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Netherlands

9. Unit of Diet, Genes, and Environment, Danish Cancer Society Research Center, Copenhagen

10. Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

11. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

12. Molecular and Genetic Epidemiology Unit, Human Genetics Foundation, Torino, Italy

13. Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute–Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy

14. Department for Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, Netherlands

15. Unit of Nutirition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain

16. Department of Epidemiology, Murcia Regional Health Council, Biomedical Research Institute of Murcia (IMIB-Arrixaca), Murcia, Spain

17. Centro de Investigación Biomédica en Red Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

18. Public Health Direction and Biodonostia Research Institute–CIBERESP, San Sebastian, Spain

19. Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria, Granada, Spain

20. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain

21. Epidemiology, Prevention, and Promotion Health Service, Navarra Public Health Institute, Pamplona, Spain

22. Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra Institute for Health Research, Pamplona, Spain

23. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

24. Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke

25. Divison of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg

26. Hellenic Health Foundation, Athens, Greece

27. World Health Organization Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

28. Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts

29. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy

30. Université Paris-Saclay, Université Paris-Sud, Université de Versailles Saint-Quentin-en-Yvelines, Centre de Recherche en Epidémiologie et Santé des Populations, National Institute for Health and Medical Research (INSERM), Villejuif, France

31. Department of Community Medicine, Universtiy of Tromsø, Arctic University of Norway, Tromsø

32. Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway

33. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

34. Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland

35. Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece

36. Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden

37. Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

38. Public Health Sciences Division, Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2687371/jamaoncology_guida_2018_br_180010.pdf

Reference15 articles.

1. Reduced lung-cancer mortality with low-dose computed tomographic screening.;National Lung Screening Trial Research Team;N Engl J Med,2011

2. Lung cancer risk prediction model incorporating lung function: development and validation in the UK Biobank Prospective Cohort Study.;Muller;J Clin Oncol,2017

3. Circulating inflammation markers and prospective risk for lung cancer.;Shiels;J Natl Cancer Inst,2013

4. Pro-surfactant protein B as a biomarker for lung cancer prediction.;Sin;J Clin Oncol,2013

5. Circulating pro-surfactant protein B as a risk biomarker for lung cancer.;Taguchi;Cancer Epidemiol Biomarkers Prev,2013

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations;Tumor Biology;2024-01-23

2. Plasma protein signatures of adult asthma;Allergy;2024-01-23

3. Cohort Profile: The Taihu Biobank of Tumour Biomarkers (TBTB) study in Wuxi, China;International Journal of Epidemiology;2023-12-18

4. Liquid biopsy for early detection of lung cancer;Chinese Medical Journal Pulmonary and Critical Care Medicine;2023-12

5. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration;Cancer Letters;2023-11